This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Crocchiolo R, Nicolini FE, Sobh M, Ducastelle-Lepretre S, Labussiere H, Dubois V et al. Treatment of a severe extensive cutaneous chronic GVHD after allo-HSCT using glycerolyzed skin allografts and cultured epidermis from the same donor. Bone Marrow Transplant 2011; 46: 1153–1155.
Prehn RT, Main JM . A comparison between heterozygous and homozygous skin homografts. J Natl Cancer Inst 1954; 15: 191–194.
Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M . Haematopoietic chimera in man after allogeneic (homologous) bone-marrow transplantation. Br Med J 1963; 2: 1633–1635.
Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M, Devries MJ et al. Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemic effects. Blood 1965; 25: 179–196.
Knobler HY, Sagher U, Peled IJ, Wexler MR, Steiner D, Rubinstein N et al. Tolerance to donor-type skin in the recipient of a bone marrow allograft. Transplantation 1985; 40: 223–225.
De Kock J, Meuleman P, Raicevic G, Rodrigues RM, Branson S, Meganathan K et al. Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response. Stem Cells 2014; 32: 2215–2228.
Socié G, Ritz J . Current issues in chronic graft-versus-host disease. Blood 2014; 124: 374–384.
Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M . Adoptive immunotherapy of acute leukemia: experimental and clinical results. Cancer Res 1965; 25: 1525–1531.
Tan AW, Koh LP, Goh BK . Leucoderma in graft-versus-host disease: excellent repigmentation with noncultured cellular grafting. Br J Dermatol 2011; 165: 435–437.
Milner SM, Cordova AC, Leffell M, Price LA . Cultured epithelial allograft for the management of cutaneous graft-versus-host disease following stem-cell transplantation. Transplantation 2011; 92: e53–e54.
Billingham RE, Brent L, Medawar PB . Actively acquired tolerance of foreign cells. Nature 1953; 172: 603–606.
Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST . Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance. Clin Pharmacol Ther 2013; 93: 36–45.
Ravindra KV, Wu S, McKinney M, Xu H, Ildstad ST . Composite tissue allotransplantation: current challenges. Transplant Proc 2009; 41: 3519–3528.
Filipovich AH, Weisdort D, Pavletic S, Socie G, Wingard JR, Lee SJ . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Acknowledgements
We thank all personnel at the Department of Hematology of Lyon-Sud Hospital (Pierre Bénite, Lyon, France) and at the Department of Plastic Surgery of Croix Rousse Hospital (Lyon, France) for their remarkable contribution in patient’s care and assistance to her family.
Author contributions
RC conceived the treatment and wrote the manuscript; VD performed the chimerism analyses; F-EN, SD-L, HL, CA, AM, OD and FB provided clinical care; MS provided technical assistance; FC revised and commented on the manuscript; MM provided clinical care, followed the patient and supervised the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
RC is an employee of MolMed SpA at the time of submission. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Crocchiolo, R., Dubois, V., Nicolini, FE. et al. Skin allograft for severe chronic GvHD. Bone Marrow Transplant 52, 1060–1062 (2017). https://doi.org/10.1038/bmt.2017.53
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.53